Current CDC monitoring shows no Level 4 “Avoid All Travel” health notices active as of early June 2026, with the agency maintaining Level 3 advisories for the recent Ebola outbreak in the Democratic Republic of the Congo and lower-tier notices for chikungunya and dengue in affected regions. Traders assign 76.5% probability to “No” through year-end because sustained low U.S. public risk assessments, effective containment measures, and the absence of uncontrolled high-mortality pathogens with no available precautions align with historical thresholds for Level 4 issuance. Ongoing surveillance by the CDC and WHO, combined with seasonal patterns of mosquito-borne and respiratory viruses, supports expectations that conditions will not escalate to the extreme-risk category required for such a notice before December 31.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado¿Los CDC emiten una advertencia de Nivel 4 antes del 31 de diciembre?
Sí
$71,851 Vol.
$71,851 Vol.
Sí
$71,851 Vol.
$71,851 Vol.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Mercado abierto: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Current CDC monitoring shows no Level 4 “Avoid All Travel” health notices active as of early June 2026, with the agency maintaining Level 3 advisories for the recent Ebola outbreak in the Democratic Republic of the Congo and lower-tier notices for chikungunya and dengue in affected regions. Traders assign 76.5% probability to “No” through year-end because sustained low U.S. public risk assessments, effective containment measures, and the absence of uncontrolled high-mortality pathogens with no available precautions align with historical thresholds for Level 4 issuance. Ongoing surveillance by the CDC and WHO, combined with seasonal patterns of mosquito-borne and respiratory viruses, supports expectations that conditions will not escalate to the extreme-risk category required for such a notice before December 31.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes